Bioamber Inc (BIOAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,322 | -9,603 | -12,536 | -41,171 | -32,319 |
| Depreciation Amortization | 6,078 | 3,832 | 1,755 | 2,158 | 570 |
| Accounts receivable | -2,903 | -1,111 | -312 | -581 | -474 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -984 | -984 |
| Other Working Capital | -13,510 | -12,505 | -12,902 | 2,586 | 3,189 |
| Other Operating Activity | -6,444 | -6,288 | 3,710 | 5,793 | 7,528 |
| Operating Cash Flow | $-33,101 | $-25,675 | $-20,284 | $-32,199 | $-22,491 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -540 | -364 | -26 | -64,390 | -62,465 |
| Purchase Of Investment | N/A | N/A | N/A | -412 | -412 |
| Investing Cash Flow | $-540 | $-364 | $-26 | $-64,803 | $-62,878 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 28,037 | N/A | -2,383 | 29,914 | 29,914 |
| Debt Repayment | -14,081 | -4,840 | N/A | -16,059 | -585 |
| Common Stock Issued | 29,644 | 29,585 | 29,585 | 42,177 | 42,011 |
| Other Financing Activity | -1,370 | -571 | -198 | -1,144 | -882 |
| Financing Cash Flow | $42,231 | $24,174 | $27,005 | $54,888 | $70,457 |
| Exchange Rate Effect | 376 | 434 | 391 | -1,956 | -1,926 |
| Beginning Cash Position | 6,974 | 6,974 | 6,974 | 51,043 | 51,043 |
| End Cash Position | 15,940 | 5,543 | 14,059 | 6,974 | 34,206 |
| Net Cash Flow | $8,966 | $-1,431 | $7,085 | $-44,069 | $-16,837 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,101 | -25,675 | -20,284 | -32,199 | -22,491 |
| Capital Expenditure | -540 | -364 | -26 | -64,390 | -62,465 |
| Free Cash Flow | -33,641 | -26,039 | -20,311 | -96,589 | -84,956 |